Magnapime-TZ 281.25 mg Injection

Cefepime 250 mg & Tazobactam 31.25 mg
Pack : 20 ml Vial with 20 ml WFI & Insert in Mono Carton
Enquiry

Description

Magnapime-TZ 281.25 mg Injection

Cefepime 250 mg & Tazobactam 31.25 mg
 Antibiotic | Anti-Infective
20 ml Vial with 20 ml WFI & Insert in Mono Carton

 

  • Adults : 1g IV every 8-12 hrs, max 3g/day
  • Children & Infants : 30-100mg/kg/day in 2-3 divided does or as directed by physician
Product Description

Magnapime-TZ 281.25 mg Injection is prescribed to treat various types of bacterial infections. It fights against the infection by preventing the growth of microorganisms.

Benefits

Treatment of Bacterial infections

Direction For Use
  • Magnapime-TZ 281.25 mg Injection is generally given under the supervision of a doctor or a nurse and should not be self-administered. The doctor will decide the dose and duration of the treatment.
Mechanism of Action

Magnapime-TZ 281.25 mg Injection is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria.

Also Available

Additional information

Dosage Form

Therapeutic Segment

,

Related Products

error: Content is protected !!